CLEARSIDE BIOMEDICAL INC (CLSD)
US1850631045 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.58M 274.90% | 1.33M -95.50% | 8.226M 518.50% | 1.587M -80.71% | 3.045M 91.87% | 11.412M 274.78% | 23.688M 107.57% | 75.9M 220.42% | 167.85M 121.15% | 272.93M 62.60% | 297.18M 8.89% | |
| EBITDA YoY % growth | -440K 97.52% | -30.13M -6,747.73% | -24.777M 17.77% | -29.777M -20.18% | -27.561M 7.44% | -25.06M 9.07% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -620K 96.54% | -30.28M -4,783.87% | -24.844M 17.95% | -29.573M -19.03% | -38.079M -28.76% | -43.1M -13.19% | -36.718M 14.81% | -5.255M 85.69% | 69.664M 1,425.66% | 165.18M 137.11% | 211.85M 28.25% | |
| Operating Margin | -2.10% | -2,276.69% | -302.02% | -1,863.44% | -1,250.54% | -377.67% | -155.01% | -6.92% | 41.50% | 60.52% | 71.29% | |
| EPS YoY % growth | -0.01 97.44% | -0.55 -5,400.00% | -0.53 3.64% | -0.48 10.10% | -0.46 3.67% | -0.50 -9.33% | -0.11 77.64% | 0.01 112.09% | 0.57 4,135.34% | 1.07 86.40% | 1.54 43.81% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 -36.00% | -0.12 18.40% | -0.13 -27.50% | -0.15 -47.90% | -0.18 -64.06% | -0.24 -99.17% | -0.27 -111.20% | -0.30 -100.00% | -0.29 -64.57% |
| Revenue Q2Q % growth | 216.24K -96.59% | 204K -11.30% | 204K 126.67% | 204K -80.35% | 204K -5.66% | 9.045M 4,333.82% | 9.09M 4,355.88% | 9.136M 4,378.43% | 9.182M 4,400.98% |
| EBITDA Q2Q % growth | -7.609M -167.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.184M -146.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.10 33.33% | -0.13 | 0.03 | 21.12% |
| Q2 2024 Q2Q % growth | -0.10 33.33% | -0.14 | 0.04 | 27.38% |
| Q1 2024 Q2Q % growth | -0.15 | -0.14 | -0.01 | -6.87% |
| Q4 2023 Q2Q % growth | -0.08 50.00% | -0.09 | 0.01 | 10.36% |
| Q3 2023 Q2Q % growth | -0.15 -15.38% | -0.16 | 0.01 | 5.12% |
| Q2 2023 Q2Q % growth | -0.15 -15.38% | -0.14 | -0.01 | -3.80% |
| Q1 2023 Q2Q % growth | -0.15 -15.38% | -0.14 | -0.01 | -5.04% |
| Q4 2022 Q2Q % growth | -0.16 -151.61% | -0.13 | -0.03 | -24.49% |
| Q3 2022 Q2Q % growth | -0.13 -62.50% | -0.03 | -0.10 | -274.86% |
| Q2 2022 Q2Q % growth | -0.13 -18.18% | -0.13 | 0.00 | 3.45% |
| Q1 2022 Q2Q % growth | -0.13 | -0.08 | -0.05 | -55.43% |
| Q4 2021 Q2Q % growth | 0.31 321.43% | 0.16 | 0.15 | 91.95% |
| Q3 2021 Q2Q % growth | -0.08 -60.00% | -0.09 | 0.01 | 7.73% |
| Q2 2021 Q2Q % growth | -0.11 15.38% | -0.13 | 0.02 | 15.96% |
| Q1 2021 Q2Q % growth | -0.13 -85.71% | -0.10 | -0.03 | -30.05% |
| Q4 2020 Q2Q % growth | -0.14 -100.00% | -0.12 | -0.02 | -20.40% |
| Q3 2020 Q2Q % growth | -0.05 70.59% | -0.12 | 0.07 | 57.98% |
| Q2 2020 Q2Q % growth | -0.13 40.91% | -0.12 | -0.01 | -7.49% |
| Q1 2020 Q2Q % growth | -0.07 84.44% | -0.12 | 0.05 | 39.80% |
| Q4 2019 Q2Q % growth | -0.07 89.71% | -0.07 | 0.00 | 6.41% |
| Q3 2019 Q2Q % growth | -0.17 77.33% | -0.16 | -0.01 | -4.17% |
| Q2 2019 Q2Q % growth | -0.22 66.15% | -0.40 | 0.18 | 45.05% |
| Q1 2019 Q2Q % growth | -0.45 27.42% | -0.41 | -0.04 | -9.61% |
| Q4 2018 Q2Q % growth | -0.68 | -0.58 | -0.10 | -17.73% |
| Q3 2018 Q2Q % growth | -0.75 | -0.64 | -0.11 | -17.41% |
| Q2 2018 Q2Q % growth | -0.65 | -0.59 | -0.06 | -10.59% |
| Q1 2018 Q2Q % growth | -0.62 | -0.59 | -0.03 | -4.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.038M 20.84% | 125.317K | 912.683K | 728.30% |
| Q2 2024 Q2Q % growth | 90K -91.16% | 129.203K | -39.203K | -30.34% |
| Q1 2024 Q2Q % growth | 230K 5,650.00% | 596.7K | -366.7K | -61.45% |
| Q4 2023 Q2Q % growth | 6.345M 1,822.73% | 4.522M | 1.823M | 40.31% |
| Q3 2023 Q2Q % growth | 859K 218.15% | 163.373K | 695.627K | 425.79% |
| Q2 2023 Q2Q % growth | 1.018M 167.89% | 126.684K | 891.316K | 703.57% |
| Q1 2023 Q2Q % growth | 4K -98.86% | 146.88K | -142.88K | -97.28% |
| Q4 2022 Q2Q % growth | 330K -98.72% | 97.92K | 232.08K | 237.01% |
| Q3 2022 Q2Q % growth | 270K -91.21% | 6.648M | -6.378M | -95.94% |
| Q2 2022 Q2Q % growth | 380K -51.28% | 382.5K | -2.5K | -0.65% |
| Q1 2022 Q2Q % growth | 350K 1,066.67% | 2.933M | -2.583M | -88.07% |
| Q4 2021 Q2Q % growth | 25.69M 256,800.00% | 18.127M | 7.563M | 41.72% |
| Q3 2021 Q2Q % growth | 3.07M -10.50% | 2.629M | 441K | 16.77% |
| Q2 2021 Q2Q % growth | 780K 122.86% | 589.733K | 190.267K | 32.26% |
| Q1 2021 Q2Q % growth | 30K -99.27% | 2.165M | -2.135M | -98.61% |
| Q4 2020 Q2Q % growth | 10K -99.48% | 1.316M | -1.306M | -99.24% |
| Q3 2020 Q2Q % growth | 3.43M 2,350.00% | 1.548M | 1.882M | 121.58% |
| Q2 2020 Q2Q % growth | 350K 600.00% | 1.359M | -1.009M | -74.25% |
| Q1 2020 Q2Q % growth | 4.1M 8,100.00% | 2.04M | 2.06M | 100.98% |
| Q4 2019 Q2Q % growth | 1.94M 6,366.67% | 3.73M | -1.79M | -47.99% |
| Q3 2019 Q2Q % growth | 140K | 15.3K | 124.7K | 815.03% |
| Q2 2019 Q2Q % growth | 50K | 6.559K | 43.441K | 662.36% |
| Q1 2018 Q2Q % growth | 14.617K | -14.617K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 20.99% | 20.99% | 3.56% | 3.84% |
| Revenue | 73.06% | 73.06% | 153.64% | 153.64% |